Pharvaris N.V. (PHVS)

Market Closed

5 Dec, 20:00

NASDAQ (NGS)

26. 42

-1.27

-4.59%

1.8B Market Cap

- P/E Ratio

0% Div Yield

455,951 Volume

-2.5 Eps

$ 27.69

Previous Close

Day Range

25.86 27.91

Year Range

11.51 29.8

Want to track PHVS and more in your Portfolio? 🎯

Get Started For Free

Pharvaris N.V. (PHVS) Discusses Topline Data From RAPIDe-3 Phase III Study of Deucrictibant for Hereditary Angioedema Transcript

Seekingalpha | 4 days ago

Pharvaris N.V. (PHVS) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Pharvaris N.V. (NASDAQ:PHVS ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 3:45 PM EDT Company Participants Peng Lu - Chief Medical Officer Conference Call Participants Tiago Fauth - Wells Fargo Securities, LLC, Research Division Presentation Tiago Fauth Equity Analyst My name is Tiago Fauth.

Seekingalpha | 3 months ago

Pharvaris N.V. (PHVS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Pharvaris N.V. (NASDAQ:PHVS ) Cantor Global Healthcare Conference 2025 September 3, 2025 11:30 AM EDT Company Participants Wim Souverijns - Chief Commercial Officer Peng Lu - Chief Medical Officer Conference Call Participants Steven Seedhouse - Cantor Fitzgerald & Co., Research Division Presentation Steven Seedhouse MD & Biotechnology Analyst Okay.

Seekingalpha | 3 months ago

Affiliate Program About Terms Privacy Help Contact Us